# Gestala

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/gestala

- Industry: Medical Devices & Equipment
- Headquarters: Chengdu, China
- Website: www.gestala.com
- Total disclosed funding: $84M
- Latest round: Angel (Jul 3, 2026)
- Investors on record: 16

## About

Bases in Chengdu, China, and founded in 2025, Gestala (Chengdu) Technology Co., Ltd., trading as Gestala, focusing on the development of advanced brain-computer interface technologies. The company recently pivoted its business strategy to enhance their product offerings in the neuromodulation sector.
In July 2026, Gestala raised CNY 420 million in Angel+ funding led by Meridian Capital, with participation from C Capital, HSG, Lens Technology, Zhongdian Shurong Investment Management, Sinovation Ventures, Linchuang Capital, Furong Capital, GoldTech Capital, Dalton Venture, Seas Capital, Tsing Song Capital, Gobi Partners, and other investors. 
Gestala specializes in the development of innovative brain-computer interface (BCI) technologies, specifically utilizing ultrasound neuromodulation techniques. Their core product offerings focus on non-invasive solutions designed to facilitate communication between the human brain and external devices, with applications aimed at addressing various neurological conditions and enhancing cognitive functions. The ultrasound BCI systems target chronic pain management, stroke rehabilitation, and treatment of post-traumatic stress disorder (PTSD), offering substantial benefits to healthcare providers and users. Their products are primarily marketed within China, with plans to expand into international markets.
Gestala generates revenue through strategic partnerships and collaborations with healthcare institutions and research organizations, alongside potential direct-to-consumer sales for their ultrasound BCI technologies. They may employ subscription-based models or service agreements where clients can access ongoing support and updates. The flagship products are tailored for clinical settings and are expected to be integrated into treatment protocols, enhancing patient care. Specific pricing plans and service agreements are contingent on deployment scale and customization needs.
Gestala aims to build whole-brain ultrasound brain-computer interface platforms, advance the treatment of neurological disorders through non-invasive neurotechnology, and explore the future convergence of neuroscience and artificial intelligence.

## Funding rounds

- Angel, Jul 3, 2026, $62M — Gobi Partners, Sinovation Ventures, Meridian Capital, Furong Capital, C Capital, Dalton Venture, HSG, Linchuang Capital, Lens Technology, Tsing Song Capital, Zhongdian Shurong Investment Management, GoldTech Capital, Seas Capital
- Angel, Mar 12, 2026, $22M — Gobi Partners, Liepin.com, Dalton Venture, Shanghai Fourier Intelligence Co. Ltd., Tsing Song Capital, Seas Capital, BIO-TOWN Capital

## Investors

- Gobi Partners (https://capitalatlas.ai/funds/gobi-partners) — Angel
- Liepin.com — Angel
- Dalton Venture (https://capitalatlas.ai/funds/dalton-venture) — Angel
- Shanghai Fourier Intelligence Co. Ltd. — Angel
- Tsing Song Capital (https://capitalatlas.ai/funds/tsing-song-capital) — Angel
- Seas Capital (https://capitalatlas.ai/funds/seas-capital) — Angel
- BIO-TOWN Capital (https://capitalatlas.ai/funds/bio-town-capital) — Angel
- Sinovation Ventures (https://capitalatlas.ai/funds/sinovation-ventures) — Angel
- Meridian Capital — Angel
- Furong Capital (https://capitalatlas.ai/funds/furong-capital) — Angel
- C Capital (https://capitalatlas.ai/funds/c-capital) — Angel
- HSG (https://capitalatlas.ai/funds/hsg) — Angel
- Linchuang Capital (https://capitalatlas.ai/funds/linchuang-capital) — Angel
- Lens Technology — Angel
- Zhongdian Shurong Investment Management (https://capitalatlas.ai/funds/zhongdian-shurong-investment-management) — Angel
- GoldTech Capital (https://capitalatlas.ai/funds/goldtech-capital) — Angel